Quest Diagnostics Total Cost of Revenue increased by 3.0% to $1.95B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.2%, from $1.79B to $1.95B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 2.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.57B | $1.67B | $1.72B | $1.65B | $1.61B | $1.62B | $1.58B | $1.56B | $1.55B | $1.54B | $1.55B | $1.60B | $1.59B | $1.68B | $1.76B | $1.79B | $1.82B | $1.87B | $1.90B | $1.95B |
| QoQ Change | — | +6.7% | +2.9% | -4.2% | -2.1% | +0.4% | -2.7% | -1.0% | -0.9% | -0.3% | +0.7% | +2.8% | -0.1% | +5.3% | +5.1% | +1.5% | +1.6% | +2.7% | +1.6% | +3.0% |
| YoY Change | — | — | — | — | +2.9% | -3.1% | -8.3% | -5.2% | -4.0% | -4.8% | -1.5% | +2.2% | +3.0% | +8.8% | +13.6% | +12.2% | +14.1% | +11.3% | +7.5% | +9.2% |